AMT-562
AMT-562 is an antibody-drug conjugate (ADC) consisting of a novel anti-HER3 antibody Ab562 (HY-P991505) conjugated to the linker MC-VA-PAB and the topoisomerase I inhibitor Exatecan (HY-13631) . The ADC toxic molecule and linker portion are MC-VA-PAB-Exatecan (HY-147270) . AMT-562 can induce apoptosis and has antitumor activity against pancreatic, esophageal, and gastric cancers[1][2].
Product Specifications
UNSPSC
12352203
Target
Antibody-Drug Conjugates (ADCs) ; Apoptosis; EGFR; Topoisomerase
Related Pathways
Antibody-drug Conjugate/ADC Related; Apoptosis; Cell Cycle/DNA Damage; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
[AMT-562]
References & Citations
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
No Development Reported
Isoform
ErbB3/HER3; Topo I
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NMNAT1, Recombinant, Human, aa115-270, His-Tag (Nicotinamide nucleotide adenylyltransferase 1, NMNAT, PNAT1)
NMNAT1, Recombinant, Human, aa115-270, His-Tag (Nicotinamide nucleotide adenylyltransferase 1, NMNAT, PNAT1)
